Xiaozheng pill exerts an anti-mammary hyperplasia effect through Raf/ERK/ELK and HIF-1α/bFGF pathways

10.1016/j.jtcme.2023.05.002

Yu-fei Liu；Tian An；Hong Yu；Ying-yi Fan；Xiao-hua Pei

Hyperplasia of mammary glands ； Xiaozheng pill (XZP) ； Angiogenesis ； Apoptosis ； Metabolomics

Journal of Traditional and Complementary Medicine

13卷6期（2023 / 11 / 01）

600 - 610

英文

Background and aim: The purpose of this study is to explore whether the Xiaozheng pill (XZP) has the effect of anti-hyperplasia of mammary glands (HMG) and to identify the related signaling pathways. Experimental procedure: We analyzed the effective chemical components of the XZP, as well as the key chemical components, key proteins, main biological processes, and pathways in the treatment of HMG; Secondly, the levels of Estradiol (E2), Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Progesterone (P), Raf/ERK/ELK and HIF-1α/bFGF pathways related proteins were detected; Finally, the effect of XZP on metabolites was analyzed by metabolomics. Results and conclusion: In this study, we identified key targets and pathways for XZP therapy of HMG, including EGFR, VEGFA, ER, and Ras signaling pathways. Animal experiments show that XZP can reduce the levels of E2, LH, and FSH and increase the expression of P in HMG mice. XZP can restore the normal structure of breast tissue and reduce ERα, ERβ, and PR expression in breast tissue. In addition, metabolomics results show that XZP also regulates HMG metabolites, including HIF-1α and metabolic pathways. The Western blot results showed that XZP intervention can reduce the protein expression of p- Raf1, Raf1, p-ERK1/2, ERK1/2, ELK, HIF-1α, and bFGF in the breast tissue of HMG mice. XZP may eliminate abnormal breast hyperplasia through inhibition of apoptosis and angiogenesis, which may be linked with the regulation of the Raf/ERK/ELK and HIF-1α/bFGF signaling pathways in HMG mice. These results suggest that XZP treatment may be beneficial for the management of HMG.

1. Adeniji-Sofoluwe, AT,Obajimi, GO,Obajimi, MO(2015).Pregnancy related breast diseases in a developing African country: initial Sonographic Evaluation.Pan Afr Med J,20,239.
2. Adeola, HA,Papagerakis, S,Papagerakis, P(2019).Systems biology approaches and precision oral health: a circadian clock perspective.Front Physiol,10,399.
3. Bluff, JE,Menakuru, SR,Cross, SS(2009).Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.Br J Cancer,101(4),666-672.
4. Cagnol, S,Chambard, JC(2010).ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence.FEBS J,277(1),2-21.
5. Chen, T,Li, J,Chen, J,Song, H,Yang, C(2015).Anti-hyperplasia effects of Rosa rugose polyphenols in rats with hyperplasia of mammary gland.Environ Toxicol Pharmacol,39(2),990-996.
6. Gao, H,Yang, C,Fan, J,Lan, L,Pang, D(2021).Hereditary and breastfeeding factors are positively associated with the aetiology of mammary gland hyperplasia: a case-control study.Int Health,13(3),240-247.
7. Going, JJ,Anderson, TJ,Wyllie, AH(1992).Ras p21 in breast tissue: associations with pathology and cellular localisation.Br J Cancer,65(1),45-50.
8. Gong, Lei,Zhao, Xiaoli,Di, Liuqing(2013).Etc establishment of HPLC fingerprint of Xiaozheng pill and its methodological study [C]//Traditional Chinese medicine preparations branch of China association of Chinese medicine, professional committee of traditional Chinese medicine of world federation of Chinese medicine societies.Proceedings of the "Good Doctor Cup" Forum on Innovation and Development of Traditional Chinese Medicine Preparations
9. Gregory, KJ,Roberts, AL,Conlon, EM(2019).Gene expression signature of atypical breast hyperplasia and regulation by SFRP1.Breast Cancer Res,21(1),76.
10. Haghighi, F,Dahlmann, J,Nakhaei-Rad, S(2018).bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling.Cell Commun Signal,16(1),96.
11. Hilton, HN,Clarke, CL,Graham, JD(2018).Estrogen and progesterone signalling in the normal breast and its implications for cancer development.Mol Cell Endocrinol,466,2-14.
12. Jacob, M,Lopata, AL,Dasouki, M,Abdel, Rahman AM(2019).Metabolomics toward personalized medicine.Mass Spectrom Rev,38(3),221-238.
13. Jia, Y,Liu, X,Jia, Q(2017).The anti-hyperplasia of mammary gland effect of protein extract HSS from Tegillarca granosa.Biomed Pharmacother,85,1-6.
14. Jiang, M,Liang, Y,Pei, Z(2019).Diagnosis of breast hyperplasia and evaluation of RuXian-I based on metabolomics deep belief networks.Int J Mol Sci,20(11),2620.
15. Jing, X,Yang, F,Shao, C(2019).Role of hypoxia in cancer therapy by regulating the tumor microenvironment.Mol Cancer,18(1),157.
16. Johnson, CH,Ivanisevic, J,Siuzdak, G(2016).Metabolomics: beyond biomarkers and towards mechanisms.Nat Rev Mol Cell Biol,17(7),451-459.
17. Kasza, A(2013).Signal-dependent Elk-1 target genes involved in transcript processing and cell migration.Biochim Biophys Acta,1829(10),1026-1033.
18. Li, P,Huang, J,Wu, H,Fu, C,Li, Y,Qiu, J(2016).Impact of lifestyle and psychological stress on the development of early onset breast cancer.Medicine,95(50),e5529.
19. Li, X,Shi, G(2021).Therapeutic effects and mechanism of ferulic acid and icariin in mammary gland hyperplasia model rats via regulation of the ERK pathway.Ann Transl Med,9(8),666.
20. Li, X,Xin, P,Wang, C,Wang, Z,Wang, Q,Kuang, H(2017).Mechanisms of traditional Chinese medicine in the treatment of mammary gland hyperplasia.Am J Chin Med,45(3),443-458.
21. Li, Y,Zhang, MZ,Zhang, SJ(2023).HIF-1a inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF/VEGFR1-induced macrophage polarization.Biomed Pharmacother,161,114423.
22. Lilleborge, M.,Falk, R.S.,Sørlie, T.,Ursin, G.,Hofvind, S.(2021).Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion.Int J Cancer,149(6),1247-1256.
23. Liu, Y,An, T,Wan, D,Yu, B,Fan, Y,Pei, X(2020).Targets and mechanism used by cinnamaldehyde, the main active ingredient in cinnamon, in the treatment of breast cancer.Front Pharmacol,11,582719.
24. Liu, Yang,Wang, Wenbin,Miao, Wenqing,Huang, Ming,Chen, Daping(2016).Clinical study on Xiaozheng pill in the treatment of hyperplasia of mammary glands.Information of traditional Chinese medicine,33(4),93-96.
25. Liyan, G,Jingru, X,Qi, L(2016).Effect of Jiedu Capsule on the expression of VEGF and bFGF in rats with hyperplasia of mammary glands.Chinese Journal of traditional Chinese medicine,34(7),1559-1562.
26. Longatto Filho, A,Costa, SM,Milanezi, F(2007).Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography.Oncol Rep,18(5),1201-1206.
27. Ma, D,Liu, G,Zhang, X,Zhang, Q,Gao, T,Liu, M(2020).Massage treatment of hyperplasia of mammary glands: a protocol for a systematic review and meta-analysis.Medicine,99(52),e23601.
28. Mao, X,Qiao, Z,Fan, C(2016).Expression pattern and methylation of estrogen receptor a in breast intraductal proliferative lesions.Oncol Rep,36(4),1868-1874.
29. McGettrick, AF,O'Neill, LAJ(2020).The role of HIF in immunity and inflammation.Cell Metabol,32(4),524-536.
30. Miao, mingsan,Wen, Yajuan,Ming, Bai(2017).Preparation standard of mammary gland hyperplasia animal model.Chinese Journal of experimental prescriptions,23(24),17-22.
31. Mo, FF,An, T,Zhang, ZJ(2017).Tang xiao ke granule play an anti-diabetic role in diabetic mice pancreatic tissue by regulating the mRNAs and MicroRNAs associated with PI3K-akt signaling pathway.Front Pharmacol,8,795.
32. Polat, AK,Soran, A,Kanbour-Shakir, A,Menekse, E,Levent Balci, F,Johnson, R(2016).The role of molecular biomarkers for predicting adjacent breast cancer of Atypical Ductal Hyperplasia diagnosed on core biopsy.Cancer Biomarkers,17(3),293-300.
33. Wang, C,Liu, C,Wang, M(2018).UPLC-HRMS-Based plasma metabolomic profiling of novel biomarkers by treatment with KDZI in cerebral ischemia reperfusion rats.Molecules,23(6),1315.
34. Wang, Jiangang,Qi, Chen,Yan, zhangren,Wang, Wanchun(2018).Clinical observation of Xiaozheng pill in the treatment of hyperplasia of mammary glands.Modern distance education of traditional Chinese medicine,16(6),118-120.
35. Wang, R,Li, B,Lam, SM,Shui, G(2020).Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression.J Genet Genomics,47(2),69-83.
36. Warner, M,Wu, WF,Montanholi, L,Nalvarte, I,Antonson, P,Gustafsson, JA(2020).Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERb gene.Proc Natl Acad Sci U S A,117(9),4902-4909.
37. Wei, S,Zhou, X,Niu, M(2019).Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland.Mol Genet Genom,294(5),1159-1171.
38. Wei, S,Zhou, X,Niu, M(2019).Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland.Mol Genet Genom,294(5),1159-1171.
39. Xiaochen, H,Shulan, S,Jianming, G(2014).Application and thinking of metabolomics in the research of some scientific problems of traditional Chinese medicine.Chin Tradit Herb Drugs,45(2),147-153.
40. Xu, Shuyun(2002).Pharmacological Experimental Methodology.Beijing:People's Health Publishing House.
41. Xue, W,Pinghu, Z(2017).Research progress of Ras/Raf/MEK/ERK signaling pathway involved in autophagy regulation.J China Pharm Univ,48(1),110-116.
42. Yang, H,Tan, M,Gao, Z,Wang, S,Lyu, L,Ding, H(2023).Role of hydrogen sulfide and hypoxia in hepatic angiogenesis of portal hypertension.J Clin Transl Hepatol,11(3),675-681.
43. Yixuan, W,Ke, W,Shu, Z(2020).Research progress of Elk-1 regulating skeletal system function.Chin J Osteoporos,26(12),1857-1860.
44. Yong, HY,Hwang, JS,Son, H(2011).Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells.Neoplasia,13(2),98-107.
45. You, Z,Sun, J,Xie, F(2017).Modulatory effect of fermented papaya extracts on mammary gland hyperplasia induced by estrogen and progestin in female rats.Oxid Med Cell Longev,2017,8235069.
46. Zhang, JF,Liu, J,Gong, GH,Zhang, B,Wei, CX(2019).Mongolian medicine RuXian-I treatment of estrogen-induced mammary gland hyperplasia in rats related to TCTP regulating apoptosis.Evid Based Complement Alternat Med,2019,1907263.